ÂÜÀòÂÒÂ×

Chelsea Jarvis, MHM, currently serves as a Clinical Research Coordinator at IMA Clinical Research, where responsibilities include conducting clinical trials in accordance with FDA requirements, GCP guidelines, and sponsor protocols. With extensive experience in investigational device, medicine, and vaccine studies addressing various indications such as major depressive disorder, treatment-resistant depression, general anxiety disorder, Alzheimer’s disease, metabolic disorders, cardiovascular disease, COVID-19, and shingles, Chelsea has previously held significant roles at NanoDx, Inc. as a Biochemistry Manufacturing Lead, Senior Research Associate, and Research Associate focused on point-of-care devices for traumatic brain injuries. Chelsea also has research experience from The University of New Mexico and the University of Arizona, complemented by a Master's degree in Healthcare Management and a Bachelor of Science in Cell/Cellular and Molecular Biology, both from the University of Arizona.